| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,409 |
3,953 |
$733K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,660 |
1,101 |
$345K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,371 |
2,025 |
$327K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,303 |
5,658 |
$317K |
| 36415 |
Collection of venous blood by venipuncture |
6,758 |
5,474 |
$61K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,023 |
840 |
$59K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,143 |
2,559 |
$38K |
| 80053 |
Comprehensive metabolic panel |
1,619 |
1,353 |
$28K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
490 |
422 |
$25K |
| A0425 |
Ground mileage, per statute mile |
753 |
549 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
410 |
346 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
246 |
199 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
210 |
188 |
$16K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
36 |
35 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
282 |
233 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
155 |
148 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
173 |
147 |
$10K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22 |
12 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
120 |
101 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
76 |
69 |
$5K |
| 80061 |
Lipid panel |
192 |
185 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
129 |
120 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
114 |
36 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
81 |
27 |
$4K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
74 |
53 |
$4K |
| 83690 |
|
282 |
237 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
70 |
62 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
102 |
87 |
$3K |
| 86140 |
|
352 |
294 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
129 |
116 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
223 |
198 |
$2K |
| 84484 |
|
105 |
81 |
$2K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
58 |
26 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
33 |
28 |
$1K |
| 87807 |
|
20 |
19 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
36 |
26 |
$843.36 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31 |
27 |
$555.89 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$276.78 |
| 87081 |
|
12 |
12 |
$211.48 |
| 81003 |
|
53 |
44 |
$185.89 |